USE OF TRIFLUOROACETYL ALKYL-SUBSTITUTED PHENYL DERIVATIVES, PHENOL DERIVATIVES, AND BENZOYL DERIVATIVES IN THE TREATMENT AND/OR PROPHYLAXIS OF OBESITY AND ACCOMPANYING DISEASES AND/OR SECONDARY DISEASES

USE OF TRIFLUOROACETYL ALKYL-SUBSTITUTED PHENYL DERIVATIVES, PHENOL DERIVATIVES, AND BENZOYL DERIVATIVES IN THE TREATMENT AND/OR PROPHYLAXIS OF OBESITY AND ACCOMPANYING DISEASES AND/OR SECONDARY DISEASES

The invention relates to the use of novel and known lipase-inhibitorily active compounds of general formula (I), wherein Al, A2, R2 and Z have the meanings as cited in the description, for the treatment and/or prophylaxis of obesity as well as accompanying diseases and/or secondary diseases associat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: SABINE (IRMER) EYTING
Format: Patent
Sprache:eng ; spa
Schlagworte:
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to the use of novel and known lipase-inhibitorily active compounds of general formula (I), wherein Al, A2, R2 and Z have the meanings as cited in the description, for the treatment and/or prophylaxis of obesity as well as accompanying diseases and/or secondary diseases associated with obesity. La invencion se refiere al uso de compuestos nuevos y conocidos, activos en la inhibicion de la lipasa, de la formula general (I), donde A1, A2, R2 y z tienen el significado mencionado en la descripcion, para el tratamiento y/o la prevencion de obesidad, asi como enfermedades acompanantes y/o segundarias relacionadas con esta.